Literature DB >> 20200142

Adrenocortical development and cancer: focus on SF-1.

Enzo Lalli1.   

Abstract

Steroidogenic factor-1 (SF-1/Ad4-binding protein; NR5A1) is an essential regulator of tissue-specific gene expression in steroidogenic cells and of adrenogonadal development. Here, I discuss recent data in the literature showing the implication of SF-1 and the importance of its dosage not only during development but also for adrenal cortex tumorigenesis in humans and mice.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20200142     DOI： 10.1677/JME-09-0143

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN： 0952-5041            Impact factor:   5.098


  14 in total

1.  FATE1 antagonizes calcium- and drug-induced apoptosis by uncoupling ER and mitochondria.

Authors:  Mabrouka Doghman-Bouguerra; Veronica Granatiero; Silviu Sbiera; Iuliu Sbiera; Sandra Lacas-Gervais; Frédéric Brau; Martin Fassnacht; Rosario Rizzuto; Enzo Lalli
Journal:  EMBO Rep       Date:  2016-07-11       Impact factor: 8.807

2.  Therapy of adrenocortical cancer: present and future.

Authors:  Daniela F Maluf; Brás H de Oliveira; Enzo Lalli
Journal:  Am J Cancer Res       Date:  2010-12-07       Impact factor: 6.166

Review 3.  Novel targeted therapies in adrenocortical carcinoma.

Authors:  Bhavana Konda; Lawrence S Kirschner
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-06       Impact factor: 3.243

Review 4.  Adrenocortical carcinoma - towards genomics guided clinical care.

Authors:  Joakim Crona; Felix Beuschlein
Journal:  Nat Rev Endocrinol       Date:  2019-09       Impact factor: 43.330

5.  Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer.

Authors:  Elisa Rossini; Mariangela Tamburello; Andrea Abate; Silvia Beretta; Martina Fragni; Manuela Cominelli; Deborah Cosentini; Constanze Hantel; Federica Bono; Salvatore Grisanti; Pietro Luigi Poliani; Guido A M Tiberio; Maurizio Memo; Sandra Sigala; Alfredo Berruti
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-26       Impact factor: 5.555

6.  ChIP-on-chip analysis reveals angiopoietin 2 (Ang2, ANGPT2) as a novel target of steroidogenic factor-1 (SF-1, NR5A1) in the human adrenal gland.

Authors:  Bruno Ferraz-de-Souza; Lin Lin; Sonia Shah; Nipurna Jina; Mike Hubank; Mehul T Dattani; John C Achermann
Journal:  FASEB J       Date:  2010-12-16       Impact factor: 5.191

7.  Knockdown of SF-1 and RNF31 affects components of steroidogenesis, TGFβ, and Wnt/β-catenin signaling in adrenocortical carcinoma cells.

Authors:  Anna Ehrlund; Philip Jonsson; Lise-Lotte Vedin; Cecilia Williams; Jan-Åke Gustafsson; Eckardt Treuter
Journal:  PLoS One       Date:  2012-03-09       Impact factor: 3.240

8.  Sunitinib Inhibits Cell Proliferation and Alters Steroidogenesis by Down-Regulation of HSD3B2 in Adrenocortical Carcinoma Cells.

Authors:  Matthias Kroiss; Miriam Reuss; Dorothee Kühner; Sarah Johanssen; Melanie Beyer; Martina Zink; Michaela F Hartmann; Vivek Dhir; Stefan A Wudy; Wiebke Arlt; Silviu Sbiera; Bruno Allolio; Martin Fassnacht
Journal:  Front Endocrinol (Lausanne)       Date:  2011-09-09       Impact factor: 5.555

9.  Analysis of candidate genes has proposed the role of y chromosome in human prostate cancer.

Authors:  Pegah Khosravi; Javad Zahiri; Vahid H Gazestani; Samira Mirkhalaf; Mohammad Akbarzadeh; Mehdi Sadeghi; Bahram Goliaei
Journal:  Iran J Cancer Prev       Date:  2014

Review 10.  Pediatric adrenocortical tumors: what they can tell us on adrenal development and comparison with adult adrenal tumors.

Authors:  Enzo Lalli; Bonald C Figueiredo
Journal:  Front Endocrinol (Lausanne)       Date:  2015-02-18       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.